Sponsor pipeline

MeiraGTx, LLC clinical trial pipeline

4 active trials 0 recruiting 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-25

Trial completed

NCT02446249 Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding… · Phase 1

Phase 1/2		1
Phase 2		2

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT05926765	A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia	Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands	Active, Not Recruiting	2026-07-24
NCT06544798	Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia	Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands	Enrolling by Invitation	2025-10-16
Phase 1/2
NCT05894343	Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's…	Parkinson's Disease	Active, Not Recruiting	2025-08-17
Not specified
NCT05060341	Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia	Radiation-induced Xerostomia	Active, Not Recruiting	2026-07-22